Stem Cell Therapies in Systemic Sclerosis: An Updated Review

Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2020, Vol 1, Issue 2

Abstract

Systemic sclerosis systemic is a systemic autoimmune disease that ultimately leads to severe damage and failure of multiple body organs. The disease is associated with significant morbidity and mortality as well as poor response to the available immunosuppressive therapies. Stem cells particularly hematopoietic and mesenchymal stem cells have recently been shown to be not only safe but also efficacious in the treatment of patients with systemic sclerosis. Autologous transplantation of hematopoietic stem cells has become the standard of care for patients with severe systemic sclerosis. Mesenchymal stem cells, alone or in combination with other therapies, have been shown to be effective in the treatment of certain forms and complications of systemic sclerosis such as chronic sclerodermatous graft versus host disease. The review will discuss the various aspects of systemic sclerosis and it will highlight the role of hematopoietic as well as mesenchymal stem cells in the treatment of systemic sclerosis.

Authors and Affiliations

Rehab Y Al-Ansari, Khalid A Al-Anazi

Keywords

Related Articles

Utilizing Adipose Tissue-Derived Stem Cell Strategies for Obtaining Regeneration of Respiratory Tract Fistulas-A Systematic Review

Fistula of the respiratory tract represent an aberrant communication or passage among the respiratory system as well as the digestive tract or the nearby organs. They might originate congenitally or more commonly, iatr...

The Future Role of Mesenchymal Stem Cells in Tissue Repair and Medical Therapeutics: Realities and Expectations

Mesenchymal Stem Cells (MSCs); which were first described by Alexander Fridenstein in the 1960s; are heterogeneous, non-hematopoietic, adult multipotent stromal progenitor cells that are capable of self-renewal and dif...

Donor Selection is a Critical Component Using Naïve Endogenous Adult Stem Cells for the Treatment of Chronic Diseases and Traumatic Injuries

Naïve adult endogenous stem cell transplants have been used as a substitute for embryonic stem cells and/or induced pluripotent stem cells for treating individuals with autoimmune, cardiovascular, neurological, orthope...

Criteria to Distinguish Endogenous Telomerase-Positive Totipotent Stem Cells from Exosomes as Major Players in Regenerative Medicine

Endogenous adult-derived Totipotent Stem Cells (TSCs) and tissue-resident exosomes are major players in the field of regenerative medicine. TSCs provide the undifferentiated building blocks for tissue repair, while exo...

Human CO Model of Creutzfeldt - Jakob Disease (CJD) Evaluates the Effect of Putative Drugs on Prion Accumulation

Creutzfeldt Jakob Disease (CJD) is incurable and fatal neurodegenerative disease. The treatment in human is cell based models for prion disease. An induced pluripotent stem cell based models of human cerebral organ has s...

Download PDF file
  • EP ID EP698847
  • DOI http://dx.doi.org/10.46889/JRMBR.2020.1202
  • Views 103
  • Downloads 0

How To Cite

Rehab Y Al-Ansari, Khalid A Al-Anazi (2020). Stem Cell Therapies in Systemic Sclerosis: An Updated Review. Journal of Regenerative Medicine & Biology Research, 1(2), -. https://www.europub.co.uk/articles/-A-698847